TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Complete response rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Acute toxicity as measured up to 4 weeks after chemoradiation
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of AAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline levels of serum vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-hour C-peptide Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Patient Perceptions of Acne Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: plasma C-peptide AUC (mixed meal tolerance test [MMTT])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Score of the Western Ontario Rotator Cuff Index (WORC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean change in MS-related fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Normal usage rate of the equipment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Investigator Global Aesthetic Improvement Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Subject Global Aesthetic Improvement Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin lifting assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mapping of microbiota changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental developmental index (Bayley II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual and hearing impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in cardiac functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: changes in Friedreich's Ataxia symptoms and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline of lactate/pyruvate ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in baseline morning home blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in baseline serum uric acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Skin biopsy samples obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of hernia recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rise of SGOT (AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HS-CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With Treatment-Emergent Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Total severity scores of nasal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of deleterious germline mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Genetic outcomes
Primary endpoint: Change in Fugl-Meyer Assessment of the Upper Extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of severe vasospasm in digital subtraction angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Improvement of severe vasospasm in tissue oxygen partial pressure (PtiO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of severe vasospasm in transcranial Doppler
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement of severe vasospasm in CT perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the Quality of life related to urinary discomfort
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of the Urinary comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite of death, nonfatal myocardial infarction, or ischemic-driven Target-Vessel Revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Hong Kong List Learning Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adrenaline response (pmol/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Acceptation or refusal to participate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severe functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in Mini-Mental State Examination (MMSE) Score at Week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: real-world response rate (rwORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the immunotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Out-of-Hospital Cardiac Arrest (OHCA)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of In-Hospital Cardiac Arrest (IHCA)
Endpoint domain: Mortality/survival
Primary endpoint: GSR Trial 1
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Number of Cardiovascular Risk Factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline Bruininks- Oseretsky Test of Motor Proficiency II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Goal Attainment Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety Profile of Alisertib
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the plasma pharmacokinetic curve for total epicatechin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of endoscopic recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of solicited systemic and local reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in rPA neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of procedural-related bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Arm volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of glucose infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ALS Functional Rating Scale (ALSFRS-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients not qualifying for statin treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma potassium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in PANSS negative score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal Autonomic Nervous System Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Agitation in PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to post-discharge home exercise recommendations
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Statin Prescribing Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time in hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of DPYD variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in mean early morning systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in mean early morning diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Degree of control (BP < 135/85 mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrence rate of spontaneous bacterial peritonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in scratching activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported LTBI Screening Percentage by Participants on Pre- and Post-ECHO Course Surveys
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participants' Self-reported LTBI Treatment Percentages on Pre- and Post ECHO Surveys
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Brief Pain Inventory Average Interference Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Mania Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving ≥ 50% reduction in pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects experiencing at least one study-related adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: 5 years mortality
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in cosmesis
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Edinburgh Postnatal Depression Scale Score (EPDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of ACR 20% improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brown adipose tissue activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Generalized Anxiety Disorder (GAD) Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worry Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants Who Appropriately Followed the Label Instructions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: diaphragm thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Sugar Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Standard Drinks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: muscle strength and mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of interleukin 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Most Frequent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of graft-versus-host disease (GvHD) events
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of cyclosporine toxicity adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in ADHD Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of neuromuscular stiffness of the gastrocnemious muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change of elasticity of the gastrocnemious muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change of relaxation of the gastrocnemious muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to transition to oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to transition to exclusive breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-stigmatizing attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absenteeism and presenteeism rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Employee self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: High Blood Glucose Index (HBGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hallucination Change Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difficult embryo transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Minutes of Moderate or Vigorous Physical Activity Per Week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of reaching target of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pain score at recovery room
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck Hopelessness Scale (BHS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to First Relapse Event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With a Relapse Event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ophthalmometry readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Survival to birth
Endpoint domain: Mortality/survival
Primary endpoint: Behavioral Approach at posttreatment and 1-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peak Fear at posttreatment and 1-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total score of self-reported claustrophobic anxiety at posttreatment and 1-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood oxygen level-dependent (BOLD) response to food cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death after 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Daytime ambulatory systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Oral Disposition Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postoperative anal caliber
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttraumatic Stress Diagnostic Scale (PDS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time-Line Follow Back (TLFB)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Adherence to wear protocol
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Motion Sickness susceptibility
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Dietary intake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in WOMAC Pain Subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Production of acetate, propionate and butyrate in the colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Aortic Valve Peak Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Onset for Colorectal Cancer
Endpoint domain: Mortality/survival
Primary endpoint: Best Corrected Visual Acuity (BCVA) of 20/40 or Better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central Retinal Thickness (CRT) ≤250 µm on TD OCT or ≤300 µm on SD OCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first WLRI episode
Endpoint domain: Adverse events/effects
Primary endpoint: suppressed viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of relapse-free patients
Endpoint domain: Mortality/survival
Primary endpoint: Constipation Severity Scale (CSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain at that moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Achieving a Platelet Count >=50×10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Difference in Number of Cannabis Use Disorder Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Difference in Depression Subscale Scores From the HADS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Difference in Anxiety Subscale Scores From the HADS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Difference in Pain Severity Scores on the BPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Difference in Sleep Scores on the AIS
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Lactate level of synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alarm-to-needle time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac troponins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Peritumoral Brain Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Total Hip Replacement Expectations Survey scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with an abscopal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any stroke or death within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Ischemic stroke in the stented artery territory between 31 day and 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Maximum Observed Concentration (Cmax) of Pyrimethamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time 0 to t (AUC[0-t]) of Pyrimethamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal Half-life (t1/2) of Pyrimethamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of relapses of ocular inflammation per year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the smartphone face scanner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test-retest-reliability of the smartphone face scanner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-operator reliability of the smartphone face scanner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Difference in Glutamine/Glutamate Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthcare seeking behaviour
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Pain medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Visual Analog Pain scale report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Satisfaction With Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline in Positive Affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Negative Affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Event free survival at three years
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with cervical dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Frequency and grade of toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended phase 2 dose
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum levels of insulin, glucose, lipids, C-reactive protein, and HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rates of spontaneous distal ureteral stone passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of screened participants who enroll
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of participant retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quality of data available for analysis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Health and Depression Symptomology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of 18F-FDG synthesis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of cases of expulsed ureteric stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total body water measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes